Skip to main content

Table 6 The comparison of cytogenetic response between different genotype groups

From: Effects of ABCG2 C421A and ABCG2 G34A genetic polymorphisms on clinical outcome and response to imatinib mesylate, in Iranian chronic myeloid leukemia patients

Polymorphism

Genotype

(CCyR)*

(Non-CyR)**

P

C421A

CA

6 (54.5%)

5 (45.5%)

0.737

 

CC

19 (45.2%)

23 (54.8%)

 

G34A

AG

18 (48.6%)

19 (51.4%)

0.774

 

GG

7 (43.8%)

9 (56.2%)

 
  1. *Complete cytogenetic response (0% Ph + metaphases on cytogenetic analysis)
  2. **Non-cytogenetic response